Loading company…
PregLem develops biopharmaceutical treatments for women's reproductive health and fertility.
PregLem develops biopharmaceutical treatments for women's health, particularly reproductive health and fertility. Founded in 2006, the company is based in Geneva, Switzerland. Gedeon Richter Plc acquired it in October 2010 for CHF 150 million, with potential milestone payments of up to CHF 295 million.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in